The metabolic degradation and the kinetics of the cerebral uptake of N,N,N' -trimethyl-N' -(2-hy droxy-3-methyl-5 -[125Ijiodobenzyl) -1,3 -propanediamine ([l25I]HIPDM) have been studied in conscious, adult male Sprague-Dawley rats to determine its suitability as a tracer for the quantitative measurement of regional CBF (rCBF). rCBF was calculated by the indicator fraction ation and the tissue equilibration methods in experiments of different durations up to I h. The values of rCBF ob tained with [125I]HIPDM were compared with those ob tained in concurrent measurements with [l4C]iodoanti pyrine in the same animals. Results of the experiments demonstrate that [125I]HIPDM is an inadequate tracer for use with the indicator fractionation method and that any method that employs [125I]HIPDM for the determination Several tracers and methods have been proposed for the measurement of regional CBF (rCBF) since the nitrous oxide method was originally developed by Kety and Schmidt (1948) . These methods are
of rCBF must take into account its metabolic degrada tion, diffusion limitations, and bidirectional flux across the blood-brain barrier. With the tissue equilibration method, consistent determinations of rCBF may be pos sible with [125I]HIPDM by measurement of the time course of its concentration in arterial blood, corrected for the presence of 125I-labeled metabolic products, and its concentration in the brain at any time up to I h after its administration. The method may be adapted to measure rCBF in humans by means of single-photon emission to mography with [123I]HIPDM. Key Words: Cerebral blood flow-Indicator fractionation method-Partition coeffi cient-Single-photon emission tomography-Tissue equilibration method-N,N,N' -Tr imethyl-N' -(2-hy droxy-3-methyl-5-[125Ijiodobenzyl)-1 ,3-propanediamine.
generally based on kinetic models that require the measurement of a diffusible radioactive or nonra dioactive tracer in arterial blood and/or brain tissue.
The measurement of local tissue concentrations of "I-emitting radioactive tracers by single-photon emission tomography (SPECT) (Kuhl and Edwards, 1963; Kuhl et aI. , 1973; Budinger, 1980) has been investigated as a possible tool to determine rCBF following the administration of a radioisotope (Lassen et aI., 1978; Fazio et aI. , 1980; Kuhl et aI. , 1982) . To measure brain tissue concentration of tracer for the determination of rCBF by SPECT with a rotating gamma camera, it is desirable to use a tracer that is either completely trapped or achieves a stable concentration in the brain tissue for the relatively long duration (15-45 min) of the scanning time.
One of the methods proposed for measurement of rCBF by means of SPECT is a version of the indicator fractionation technique of Sapirstein (1958) . This method requires the use of a diffusible tracer and is based on a two-compart ment model that assumes no backflux of tracer from the tissue into the vascular space during the period of measurement. Kuhl and associates Lear et al. , 1982) used an iodinated mono amine, N-isopropyl-p-[123I] iodoamphetamine. An other tracer, N, N, iodobenzyl) -1, 3 -propanediamine ([125I]HIPDM) has been synthesized for this same purpose by Kung and Blau (1980) . The distribution of HIPDM in brain tissue has been reported to be proportional to regional blood flow .
The purpose of the present study was to investi gate whether [125I]HIPDM was a suitable tracer for the measurement of rCBF. Knowledge of its meta bolic degradation and of the kinetics of its uptake by brain was considered essential and preliminary to the development of any method for such a pur pose. The results of these experiments, obtained in the rat, show that measurement of rCBF with HIPDM is not possible on the basis of the indicator fractionation principle because of rapid metabo lism, incomplete extraction in brain tissues, and sig nificant backflux of the tracer from the brain tissue into the vascular compartment. The tissue equili bration model (Kety, 1951 (Kety, , 1960 of tracer distri bution between blood and tissue has therefore been considered and applied to the measurement of rCBF with [125I]HIPDM on the basis of a model that takes into account these three factors.
MATERIALS AND METHODS
Theory CBF can be measured following the administration of a highly diffusible tracer substance by the intravenous route or by inhalation. According to the Fick principle, the rate of accumulation of an inert diffusible tracer in a tissue within a defined interval of time, T, is equal to the difference in rates at which the tracer is brought to the tissue in the arterial blood and removed from it in the venous blood. This statement can be expressed mathe matically as follows:
where Ca and Cv are the arterial and the venous concen trations of the tracer, respectively, Cj is the concentration of the tracer in the tissue, F is the blood flow per unit weight of tissue, and t equals the variable time. In the case of complete extraction and trapping of the tracer in the tissue, i.e., Cv = 0, rCBF can be calculated by the in dicator fractionation method (Sapirstein, 1958) and ap-plication of the following equation derived by integrating Eq.l:
where Cj ( n is the tracer concentration in the tissue at any time T following its introduction into the circulation. For tracers that are incompletely extracted but are, however, irreversibly trapped in the tissue, Eq. 2 can be modified as follows:
where E is a constant between 0 and 1 that defines the unidirectional capillary single-pass extraction fraction (Crone, 1963) .
A different approach for measurement of rCBF with a diffusible tracer has been designed by Kety (1951) on the basis of the following relationship between the arterial venous and the arterial-tissue concentration differences of tracer substance:
(4) where A. is the tissue-blood partition coefficient for the tracer and m was defined by Kety (1951) as a constant between 0 and 1 that defines the extent to which diffusion equilibrium between blood and tissue is achieved during passage from the arterial to the venous end of the capil lary. In the absence of arteriovenous shunts and diffusion limitations, m = 1. Combining Eqs. 1 and 4: Let and Thus dC mFCj -' = mFC ---
Substituting Kj and k 2 in Eq. 5:
Integrating between time 0 and time T and rearranging, Eq. 9 becomes l' CJ n = Kj e-k2 1 ' 1 Ca(l) ek2 t dt (10)
Equation 10 can also be written as follows:
This is the equation previously used to measure rCBF with inert, radioactive, diffusible tracers (Landau et aI., 1955; Kety, 1960; Sakurada et aI., 1978) , and its use is based on the assumption of bidirectional flux of a diffus ible tracer between blood and brain tissue. By solving Eq. 11 for k 2 , with knowledge of the measured tissue concentration of the tracer at time T, the history of the arterial concentration of the tracer, and the partition coef ficient A, the value of F can be determined from Eq. 7.
As previously stated, in absence of diffusion limitations, m = 1. The diffusion of most substances across the blood-brain barrier (BBB), however, is limited to some degree, and therefore the value of m has to be known to calculate the value of F from experimentally determined values of k 2 • (Tramposh et aI., 1983) . Diethylenetriamine pentaacetic acid (D TPA) was chelated to 57CO (specific activity 413 Ci/mmol; New England Nuclear) by adding 57CO to DTPA-calcium solution (0.01 M, pH 7.0) at room temperature prior to administration (Blasberg et al., 1983) . Shortly before use, [14C]IAP and [125I]HIPDM were analyzed for radiochemical purity by means of thin layer chromatography on silica gel plates (Baker Flex silica gel IB-F; J. B. Baker Chemical Co., Phillipsburg, NJ, U.S.A.) and radioactive counting. For [125I]HIPDM, the solvent system was chloroform/ethanol/concentrated ammonium hydroxide 80:20: 1 (Rf = 0.0-0.2 for free io dide, 0.6-0.8 for HIPDM). For [14C]IAP, the solvent system was 95:5 chloroform/methanol. The [125I]HIPDM exhibited radiochemical purity between 95 and 99%.
[14C]IAP exhibited radiochemical purity of >99%.
Animals
The experiments were performed on normal, adult male Sprague-Dawley rats weighing 300-400 g. For studies of the metabolism of [125I]HIPDM in vivo and for rCBF measurement, polyethylene catheters were in serted in both femoral arteries and veins under light halo thane anesthesia on the day of the experiment. After sur gery, the rats were partially restrained by means of loose fitting abdominopelvic plaster casts that were taped to lead bricks for support. Two hours was allowed for com plete recovery from the effects of the surgery and anes thesia. Arterial blood pH, Po 2 , and Peo 2 as well as body temperature, arterial blood pressure, and hematocrit were monitored by standard methods throughout the ex perimental period to ensure normal physiological condi tions.
[ 125 I]HIPDM metabolism
The metabolism of [125I]HIPDM was studied in vivo in three rats. The animals, prepared as described above, were administered an intravenous bolus of 60-80 ILCi of [125I]HIPDM contained in 0.5 ml of saline. Timed blood samples were collected in heparinized polyethylene tubes during the following 60 min through the femoral arterial catheter. The animals were then decapitated, and the brain, lungs, and liver were quickly dissected out and J Cereb Blood Flow Metabol. Vol. 5. No. I. 1985 homogenized in ice-cold saline. Blood and tissue samples were kept on ice and immediately processed for HPLC by the addition of 100 ILl of blood or tissue homogenate to 100 ILl of nonlabeled HIPDM (9.4 mg/lOO ml water), 200 ILl 1 M sodium bicarbonate (pH 9.9), and 800 ILl ethylacetate. The mixture was vortex-mixed and centri fuged. The organic (upper) phase was removed and stored in a glass tube. The aqueous phase was reextracted with 800 ILl ethylacetate. The two organic phases were com bined and evaporated to dryness under a stream of air. The residue was dissolved in 300 ILl of the HPLC buffer (15 mM heptane sulfonic acid, 0.15% triethylamine, 5% acetic acid, adjusted to pH 2.5 with phosphoric acid). A fraction of the sample (150 ILl) was injected into the HPLC chromatograph (Waters Associates, Milford, MA, U.S.A.) equipped with a Partisil PXS ODS 5/25 column and co:pell ODS guard column (Whatman Laboratory Products, Clifton, NJ, U. S.A.). The mobile phase con sisted of HPLC buffer/acetonitrile (63:37 vol/vol) at a flow rate of 1.5 mllmin. Under these conditions, [125I]HIPDM had a retention time of 5 min. Three frac tions of interest were collected (0-5 min, 5-6.5 min, 6.5-10 min) and counted in a 'Y-ray spectrometer (Packard model 5385), along with a sample of the aqueous phase of the original extraction for determination of the frac tional amounts of pure [125I]HIPDM and 125I-labeled HIPDM metabolites.
Red cell/plasma partitioning
Two sets of experiments were performed. For the [125I]HIPDM uptake study, heparinized whole blood from Sprague-Dawley rats (5 ml; hematocrit 48%) was incu bated with gentle agitation in a glass flask at 37"C after addition of 5 ILCi [125I]HIPDM at time O. Timed samples, 100 ILl each, were taken from the flask over the following 60 min, and red blood cells (RBC) and plasma were rap idly separated by centrifugation. The radioactivity in each fraction was measured by 'Y-ray scintillation counting, and the time course of [125I]HIPDM partitioning between plasma and RBC was determined.
To assess the exchangeability of [125I]HIPDM between labeled RBC and plasma, heparinized whole blood and [125I]HIPDM were initially incubated at 37°C for 5 min. RBC and plasma were then separated by centrifugation; the plasma radioactivity was measured by 'Y-ray scintil lation counting, whereas the RBC radioactivity was cal culated by subtracting the measured plasma radioactivity from the radioactivity in total blood before centrifugation. The RBC were immediately reconstituted to the original hematocrit with fresh nonradioactive plasma and reincu bated at 37°C for 4 min. This procedure was repeated 12 times over 1 h. The ratio of RBC to plasma radioactivity was calculated for each sample.
Extraction fraction
The extraction of [125I]HIPDM during a single pass through the brain capillaries was determined in nine an imals by means of the indicator diffusion method (Crone, 1963) . [57CojDTPA was used as a nondiffusible reference tracer (Blasberg et aI., 1983) . The animals were surgically prepared under pentobarbital anesthesia (30 mg/kg i.p.). A polyethylene catheter was inserted into the left external carotid artery and extended to the common carotid bi furcation. A burr hole, 1.5 mm in diameter, was placed in the skull just above the torcular Herophili, and a metal cannula, maintained in position by a metal holder screwed into the skull, was inserted to the dura. Imme diately before the experiment, the dura was perforated to collect freely flowing mixed cerebral venous blood. Three groups of animals were used to study the extraction of [125I]HIPDM following its administration in blood, in plasma, or in saline. One hundred microcuries of [l251]HIPDM and 20 [LCi [57Co] DTPA, combined in 100 [Ll heparinized blood, plasma, or saline immediately prior to the administration, were injected through the external ca rotid artery catheter as a bolus. Samples of freely flowing venous blood from the torcular were collected sequen tially (one each second over 15 s) on filter paper discs positioned on a plastic strip. The blood-containing paper discs and samples of the injectate solution were assayed by ,,{-ray spectroscopy. 1251 and 57CO spillover was mini mized by means of narrow-channel separation of the two isotopes in the "{-ray spectrometer. The extraction frac tions, E, were calculated from the experimental data as previously described (Crone, 1963) .
rCBF measurement and determination of the rate constants for [ 125 I]HIPDM transport across the BBB rCBF and HIPDM distribution in the brain were studied in four groups of normal conscious rats prepared by the surgical procedure described above. Each group of three animals received an intravenous pulse of 65 [LCi of [l251]HIPDM contained in 0.5 ml of saline at time O. Mea surement of local rates of CBF was carried out in the same animals as previously described (Sakurada et aI., 1978) with minor modifications of the arterial sampling technique (Blasberg et aI., 1981) . Each animal received a I-min intravenous infusion at an increasing rate (to achieve a ramp arterial concentration) of 25 [LCi of [l4C]IAP in 1.5 ml of saline, beginning at 9, 29, or 59 min after the pulse of [125I]HIPDM in three of the four groups, respectively, whereas in the fourth group, [125I]HIPDM and [l4C]IAP were administered concurrently in a ramp infusion over 60 s. Timed arterial blood samples, freely flowing from the catheterized femoral artery, were col lected from the onset of [125I]HIPDM administration. Fre quent sampling was performed when the concentration of the [l251]HIPDM in blood was changing rapidly, i.e., im mediately after the intravenous bolus, and continued throughout the experimental period until the beginning of the [14C]IAP infusion. At this time, an extracorporeal ar teriovenous shunt, previously inserted to connect the other femoral artery and femoral vein (silicone rubber tube, internal diameter 1.3 mm, outside diameter 3.0 mm; LKB Instruments, Rockville, MD , U.S.A.) was opened. Beginning simultaneously with the intravenous [l4C]IAP infusion, 13 timed samples of arterial blood flowing through the shunt were collected by puncture of the tube with a 23-gauge hypodermic needle. At the end of the [14C]IAP infusion, the animals were killed by decapita tion, and the brains were quickly removed. Eleven dis crete brain regions were dissected out. The brain tissue samples were weighed in tared scintillation vials and sol ubilized by adding 0.5 ml of a quaternary ammonium base in toluene (NCS; Amersham Corp., Arlington Heights, IL, U.S.A.) to each vial. The blood samples were applied to filter paper discs in scintillation vials that had been previously weighed. They were weighed again to allow calculation by difference of the weight of each blood sample. The brain tissue samples and the blood-con-taining filter paper discs were first counted in a ,,{-ray spectrometer to assay the 1251 radioactivity, and then 1 ml of water and 10 ml of liquid scintillation phosphor solu tion (Aquasol; New England Nuclear Corp.) was added to the scintillation vials for measurement of 14C radioac tivity in a liquid scintillation spectrometer (Beckman model . At least 24 h was allowed for the elution of the tracers from the filter paper into the scintillation medium before counting. Radioactivity of all samples was determined by standard methods of isotope separation and correction for quenching by external standardization. Concentration of the tracers per unit weight of blood and tissue was determined from the amount of measured ra dioactivity and the weight of the samples.
Equation 10, which relates the tissue concentration of the tracer to the history of the tracer in the arterial blood and to the transport rate constants, K 1 and k 2 , provides the basis for determination of both K 1 and k 2 • Measure ment of radioactivity in dissected discrete brain areas provides a single measurement of the tissue concentration of the tracer at a specific time for each animal. The rate constants K 1 and k 2 for [1251]HIPDM were estimated by a nonlinear least-squares best fit of Eq. 10 to the mea sured tissue and arterial concentrations of [l251]HIPDM employing the MLAB program (Knott and Reece, 1972; Knott and Shrager, 1972) . The value of the partition coef ficient, A, for each region was estimated by the ratio K/ k 2 • The value of m for HIPDM was calculated by Eq. 7 from the values of blood flow measured with [l4C]IAP, A, and the values of k 2 for [1251]HIPDM measured in the 1min experiments in which the two tracers were admin istered concurrently as described above.
RESULTS

[ 125 I]HIPDM metabolism
One minute after the intravenous administration of [1251]HIPDM as a bolus, 23% of the radioactivity in arterial blood was contained in its metabolites. One hour after administration, the 1251-labeled me tabolites accounted for 72% of the blood radioac tivity. A variable fraction of 1251-labeled products, 3% in the early blood samples rising to 7% in the later ones, was extractable into ethylacetate but could be separated from unmetabolized [1251]_ HIPDM by HPLC. The time courses of the total radioactivity, i. e., the sum of unmetabolized [1251]HIPDM and its metabolites, as well as the per centage concentrations of [1251]HIPDM and its met abolic breakdown products in arterial blood are shown in Fig. 1 .
One hour after intravenous administration, >90% of the total radioactivity in the brain and lungs was retained in [l251]HIPDM. In contrast, only 10% of the total radioactivity in the liver was contained in [l251]HIPDM. The residual activity in these organs resulted from both ethylacetate-extractable and -nonextractable metabolites (Table 1) . RBC in hep arinized samples of whole blood kept at room tem perature (22°C) did not exhibit metabolism of onstrated. In 12 consecutive washes of RBC (pre viously equilibrated with [125I]HIPDM) with fresh plasma, their activity decreased exponentially and declined to less than one-tenth of the initial value. The partitioning between RBC and plasma was in a ratio ranging from 5: 1 to 7: 1 following each of the 12 consecutive washes.
Cerebral extraction fraction
Indicator diffusion experiments were performed while the animals were under light pentobarbital an esthesia and mild hypercarbia [Pco 2 48. 3 ± 2. 5 mm Hg (mean ± SEM)]. The concentrations of [125I]HIPDM and [57Co]DTPA in cerebral venous blood as a function of time, normalized to the rel ative concentrations of the tracers injected in the carotid artery, are shown in Fig. 2 . Three different vehicles for the intracarotid injection of the tracers were examined: saline, plasma, and whole blood.
The reported values of the [125I]HIPDM extraction ratio in brain tissue, E, are the average of the values determined only from the samples collected during the first pass of the indicators through the brain capillaries, to exclude the effects of recirculating metabolites. The mean values (± SEM) of the ex traction ratio were 78 ± 6, 87 ± 2, and 79 ± 3% (n = 3 for each group), following the injection of the tracer in saline, plasma, and whole blood, re spectively. The differences between these values were not statistically significant (Bonferroni t test).
rCBF and [ 12 SI]HIPDM rate constants for transport across the BBB
The apparent rates of rCBF were estimated in different brain regions from measured values of the tissue concentration and the history of the arterial concentration of [125I]HIPDM after the arterial input curve was corrected for the presence of me tabolites. The rCBF values were calculated by both the indicator fractionation and the tissue equilibra tion methods according to Eqs. 3 and 11, respec tively.
The apparent rates of rCBF determined with "  II  II  I '  I '  1\  , ,   I I  I  I  I [125I]HIPDM by the indicator fractionation method and Eq. 3 were plotted versus concurrent measure ments of rCBF obtained with [14C]IAP in the same animals (Fig. 3) . The values of rCBF obtained with [125I]HIPDM by the indicator fractionation method were substantially lower than those obtained with ['4C]IAP and deviated to a progressively greater de gree with increasing duration of the experimental period.
The regional rate constants for [125I]HIPDM transport across the BBB were calculated by a least-squares best-fitting routine of Eq. 10 to the measured concentrations of the tracer in discrete brain regions and the history of the arterial blood concentration in the animals killed at different times up to 1 h. The least-squares best-fit estimates of Kl and k 2 for 11 discrete regions of the brain are shown in Ta ble 2. The values of the partition coefficient A. and of the constant m, as well as the values of the half-time for the clearance of the tracer from the tissue, are included in Ta ble 2.
Values of rCBF were recalculated from the same data according to the tissue equilibration method by Eq. 11, introducing the constants, A. specific for each structure, and m, obtained by averaging the m values for all the structures. There is a high corre lation between the rates of rCBF determined with [125I]HIPDM and by the tissue equilibration method and those values obtained with [,4C]IAP at all the experimental times up to 1 h after the administra tion of [,25I]HIPDM (Fig. 4) .
DISCUSSION
The goals of these studies were to determine whether HIPDM could be used as a tracer for quan titative measurement of rCBF and whether a kinetic model and an operational equation could be derived for this. These goals seemed to be of interest be cause of the proposed use of iodine-labeled HIPDM for measurement of rCBF in human subjects with SPECT (Ell et ai., 1983; Fazio et aI., 1984; Holman et ai., 1984) . The results of the present studies in dicate that:, because of rapid metabolism, incom plete extraction from the blood, and significant ef flux of the tracer from brain tissue, the indicator ¥oO.16+0.75X r=0.88 (p<O.OO 1)
, . . The values of blood flow are presented as g blood/g tissue/min because the concentrations in blood were determined gravimetrically and not converted to volumetric units by use of specific gravity of blood.
fractionation method is unsuitable for measurement of rCBF with HIPDM. On the basis of these results, the tissue equilibration method (Kety, 1951 (Kety, , 1960 , previously used for measurement of rCBF with tri fluoroiodomethane, antipyrine, and iodoantipyrine (Landau et al. , 1955; Freygang and Sokoloff, 1958; Kety, 1960; Reivich et al. , 1969; Sakurada et al. , 1978) , appears to be more suitable for the measure ment of rCBF with [1251]HIPDM. A method for the measurement of rCBF with ra diolabeled [1251]HIPDM, based on the tissue equil ibration method, must take into account the [l25I]HIPDM metabolism, diffusion limitations, and efflux from the brain tissue occurring during the experimental procedure. The determination of the concentration of unmetabolized [125I]HIPDM, sep arated from the other radiolabeled compounds present in the arterial blood, and knowledge of the J Cereb Blood Flow Metabol, Vol. 5, No. I, 1985 kinetic properties of the tracer with respect to the BBB are therefore necessary for the quantitative measurement of rCBF.
The chromatographic analysis of arterial blood and brain tissue samples demonstrates that HIPDM is quickly metabolized in vivo. The iodine-labeled metabolites of HIPDM are present in the arterial blood in high concentration, whereas the brain radioactivity is due mainly to unmetabolized [l25I]HIPDM. It is not known whether the presence of very small quantities of metabolites in the brain tissue is due to transport of systematically produced metabolites of [125I]HIPDM across the BBB, HIPDM metabolism occurring within the brain tissue, or both. It is reasonable to assume, however, that the metabolic products of HIPDM cross the BBB very slowly because they are almost entirely hydrophilic. The separation of the [1251]HIPDM Analysis by nonlinear least-squares fit of Eq. 10 (see the text) to data obtained from 12 animals, where K I is the influx constant, k 2 is the efflux constant, " is the distribution volume (= K/k 2 ), rn is the diffusion limitation coefficient, and t 1 / is the half-life of [1 2 5I]HIPDM in brain tissue (=Ioge 2Ik 2 ). a Calculated by Eq. 7 (sei the text) with data obtained from three animals. from its metabolites in arterial blood, almost com pletely achieved by ethylacetate extraction, and the presence of only a negligible amount of radioactive metabolites in the brain tissue make possible the correct measurement of the arterial and tissue con centrations of [l25I]HIPDM necessary for measure ment of blood flow by use of the tissue equilibration method.
HIPDM is not completely extracted from the ar terial blood in passage through the brain capillaries and its diffusion across the BBB, though rapid, is still limited, as demonstrated by the single-pass ex traction fraction and by the calculated value of m, respectively. The incomplete extraction is not due to irreversible trapping of [l25I]HIPDM in blood cells. Although a high concentration ratio was found between RBC and plasma, the exchange of [J25I]HIPDM appears to be completely and rapidly reversible.
The concentration of radioactive [l25I]HIPDM in arterial blood following its intravenous adminis tration as a bolus falls rapidly after an initial peak to a low but still significant level. In arterial blood, the half-time of the unmetabolized [J25I]HIPDM, calculated between 10 and 60 min after its admin istration, is � 30 min. In our study, all the experi mental animals were given approximately the same amount of [J25I]HIPDM as a bolus, and a slight de crease was demonstrated in the final tissue concen tration of radioactive tracer in animals killed at dif ferent times between 10 and 60 min. Previous studies in monkey and human subjects (Kung and Blau, 1980; Holman et aI. , 1984) demonstrated a constant increase of tracer concentration in brain after an initial uptake (� 75% of the total uptake taking place within the first few minutes). This dis-crepancy with our results is probably due to faster metabolism and more rapid disposal of the tracer in peripheral tissues in rats. This observation suggests significant efflux of tracer from the brain tissue oc curring after the initial uptake and as soon as the concentration of the tracer in blood decreases. This efflux is suggested also by the progressively in creasing underestimation of the values of rCBF with time when the indicator fractionation method is used for rCBF measurements with HIPDM. Further support for the efflux also comes from analysis of the kinetics of HIPDM exchange across the BBB on the basis of the bicompartmental model in cluding bidirectional flux of HIPDM between the brain tissue and the blood. Although K J , the rate constant of influx, is several times greater than k 2 , the rate constant of efflux of tracer from the brain, k 2 is clearly not negligible. Determination of the rate constants K J and k 2 provides the possibility of es timating the values of the partition coefficient, A, for different brain regions. It is likely that the com bination of a significant amount of unmetabolized [J25I]HIPDM circulating in the arterial blood and of a high tissue-blood partition coefficient of [J25I]HIPDM serves to balance the efflux and results in a relatively constant concentration of tracer in brain tissue.
As a result of the use of the tissue equilibration method with [l25I]HIPDM, it is possible to obtain consistent measurements of rCBF at different times up to 1 h after administration of the tracer. The underestimation of the rCBF rates, apparent at all the different experimental times and more evident at the higher rates of rCBF (Fig. 4) , might reflect the overestimation of the value of m as experimen tally determined, particularly at a high flow rate- . .
•
. . The [l25I]HIPDM turnover rate constant k 2 differs in the various cerebral structures, indicating that the clearance of this tracer is slower in the cerebral cortical regions and the hippocampus and faster in the subcortical areas, maximally in the col liculi. This difference in the rate of [125I]HIPDM clearance leads to a lower concentration of [l25I]HIPDM in the colliculi than in the cortical re gions as equilibrium is approached. Similar effects are suggested by the previously reported results of autoradiographic studies with [l25I]HIPDM in rats (Kung et aI. , 1983) . This observation has a practical consequence: The assumption of a direct relation ship between the amount of [l25I]HIPDM retained in the tissue and rCBF at all times after its admin istration would then lead to the conclusion that blood flow is lower in the colliculi than in the cor tical regions, which is certainly not true. It is im portant to note, in fact, that the partition coefficient also varies among the different brain regions along with K l and k 2 . As described by the operational equation of the tissue equilibration method, the tissue concentration of [l25I]HIPDM, at any time after its administration, is a function of its clearance constant, k 2 ' which reflects both blood flow and tissue-blood partition coefficient. Following the bolus administration of [l25I]HIPDM, its concentra tion in the tissue immediately after the intravenous pulse is mainly a reflection of the blood flow. As the distribution of the tracer between tissue and blood tends with time to approach equilibrium, however, the brain concentration becomes more a function of the partition coefficient. It is therefore reasonable to expect changes occurring with time in the pattern of distribution of [l25I]HIPDM within the brain tissue. This same phenomenon has pre viously been observed and reported for trifluoroio domethane (Freygang and Sokoloff, 1958) .
These studies in animals provide a model for the analysis of the kinetic behavior of HIPDM in hu mans. They also indicate that the use of iodine-la beled HIPDM for quantitative measurement of rCBF in human subjects with SPECT requires the determination of several constants. In particular, the partition coefficient A must be determined for separate brain regions before any attempt can be made to correlate measurements of tissue radioac tivity with rates of regional blood flow. Knowledge of the diffusion factor m and of the metabolism of [125I]HIPDM is also necessary if quantitative mea surements are pursued. Furthermore, a time frame for measurement of the iodine-labeled HIPDM con centration in the brain tissue needs to be chosen according to the kinetic properties of the tracer in humans and according to the limitation imposed by the duration of the scanning procedure with a ro tating gamma camera. In fact, the tissue equilibra tion method used in laboratory animals is based on the instantaneous measurement of the tissue con centration of the tracer at a selected time, either by autoradiography or by the tissue-sampling tech nique. In contrast, the external measurement of ra dioactivity performed by SPECT requires a variable scanning time. The significant efflux of tracer, therefore, might represent a limitation in the use of HIPDM for rCBF measurement if SPECT is carried out with a slow-rotating gamma camera. This problem can be, however, partially overcome by use of a fast-scanning device. Furthermore, no in ferences can be made about the kinetic behavior of this tracer in pathological brain tissue. The values of the constants, m, and A used in the operational equation for measurement of rCBF with [l25I]HIPDM in physiological states are, in fact, likely to change in pathological states. Even the qualitative interpre tation of the brain images obtained with SPECT re quires at least knowledge of the regional partition coefficient of the tracer.
The results of these studies demonstrate that the indicator fractionation method is not suitable for measurement of rCBF with labeled HIPDM. The tissue equilibration method, although more suit able, still represents a relatively unsatisfactory al ternative because of the need to know the kinetic constants and metabolic degradation of HIPDM in each study in humans. Both kinetic constants and the rate of HIPDM metabolic degradation could vary among individuals and in pathological condi tions.
Therefore, the combination of HIPDM and ro tating gamma camera should not be considered as the technique of first choice for studies of CBF. SPECT carried out with a rotating gamma camera and with HIPDM, however, can become a useful diagnostic tool for the tomographic assessment of regional cerebral perfusion, provided that the ki netics of HIPDM exchange across the BBB are fully understood.
